Supplemental Material
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
Long-term safety and efficacy of risankizumab for the treatment of moderate-to-severe plaque psoriasis: Interim analysis of the LIMMitless open-label extension trial up to 5 years of follow-up
创建时间：
2023-07-08
